We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
(+6.9%)
Cap. Flow
-$4.92B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$672M |
| 2 |
Applied Materials
AMAT
|
+$241M |
| 3 |
Kenvue
KVUE
|
+$220M |
| 4 |
Salesforce
CRM
|
+$210M |
| 5 |
PayPal
PYPL
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.25B |
| 2 |
Advanced Micro Devices
AMD
|
+$526M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$443M |
| 4 |
Chubb
CB
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
3D Systems Corp
DDD
$613M
| $3.32M | ﹤0.01% |
334,474
-3,120
| -0.9% | -$28.5K |
|
2077
Zentalis Pharmaceuticals
ZNTL
$302M
| $3.31M | ﹤0.01% |
117,396
+2,885
| +3% | +$69.2K |
|
|
ATRI
2078
DELISTED
Atrion Corp
ATRI
| $3.31M | ﹤0.01% |
5,850
+192
| +3% | +$112K |
|
|
VERV
2079
DELISTED
Verve Therapeutics
VERV
| $3.3M | ﹤0.01% |
175,904
+15,180
| +9% | +$253K |
|
2080
Levi Strauss
LEVI
$9.39B
| $3.28M | ﹤0.01% |
227,381
+47,023
| +26% | +$679K |
|
|
AVNS
2081
DELISTED
Avanos Medical
AVNS
| $3.28M | ﹤0.01% |
128,291
-49,480
| -28% | -$1.3M |
|
2082
MINISO
MNSO
$3.75B
| $3.28M | ﹤0.01% |
192,900
+2,000
| +1% | +$33.4K |
|
2083
Baidu
BIDU
$37.2B
| $3.28M | ﹤0.01% |
23,923
+250
| +1% | +$32.7K |
|
|
CBAY
2084
DELISTED
Cymabay Therapeutics
CBAY
| $3.27M | ﹤0.01% |
+298,875
| New | +$2.78M |
|
2085
Rhythm Pharmaceuticals
RYTM
$7.96B
| $3.27M | ﹤0.01% |
198,443
+149,039
| +302% | +$2.69M |
|
2086
Relay Therapeutics
RLAY
$4.33B
| $3.27M | ﹤0.01% |
260,082
+9,145
| +4% | +$114K |
|
2087
Cerus
CERS
$474M
| $3.27M | ﹤0.01% |
1,327,269
+108,711
| +9% | +$258K |
|
|
SPWR
2088
DELISTED
SunPower Corporation Common Stock
SPWR
| $3.26M | ﹤0.01% |
332,951
+10,193
| +3% | +$119K |
|
2089
Erasca
ERAS
$6.39B
| $3.26M | ﹤0.01% |
1,179,712
+468,305
| +66% | +$1.33M |
|
2090
First Bancorp
FBNC
$2.68B
| $3.25M | ﹤0.01% |
109,326
+14,757
| +16% | +$467K |
|
2091
Safety Insurance
SAFT
$1.52B
| $3.23M | ﹤0.01% |
45,059
+8,802
| +24% | +$644K |
|
2092
Compass
COMP
$9.66B
| $3.23M | ﹤0.01% |
922,034
-156,428
| -15% | -$513K |
|
2093
Turning Point Brands
TPB
$1.74B
| $3.22M | ﹤0.01% |
134,058
+78,776
| +142% | +$1.77M |
|
2094
National Beverage
FIZZ
$3.01B
| $3.21M | ﹤0.01% |
66,492
-1,024
| -2% | -$51.4K |
|
2095
Heartland Express
HTLD
$956M
| $3.21M | ﹤0.01% |
195,776
+65,332
| +50% | +$1.02M |
|
2096
Vicor
VICR
$10.2B
| $3.21M | ﹤0.01% |
59,443
| – | – |
|
2097
Sweetgreen
SG
$642M
| $3.21M | ﹤0.01% |
250,138
+5,645
| +2% | +$52.2K |
|
|
NXRT
2098
NexPoint Residential Trust
NXRT
$652M
| $3.2M | ﹤0.01% |
70,335
-125,656
| -64% | -$5.42M |
|
2099
GFL Environmental
GFL
$14.9B
| $3.18M | ﹤0.01% |
82,026
-7,926
| -9% | -$288K |
|
|
DSEY
2100
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $3.18M | ﹤0.01% |
379,015
+7,010
| +2% | +$57.9K |
|
Similar funds
VFT
Nuveen's Q2 2023 Portfolio in Review
As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
- Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
- Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
- Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
- Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
- Nuveen opened 280 new positions and closed 179 in Q2 2023.
- Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.
Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.